Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 70377-126

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 70377-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Image01)

This text provides detailed information about a medication called Mycophenolate sodium, USP, contained in delayed-release tablets. The dosage and storage instructions, as well as manufacturing details, are included. It is important to dispense the medication at the appropriate temperature and protect it from moisture. The text also emphasizes keeping the medication out of the reach of children and includes contact information for the manufacturers.*

FDA Label Image

Bottle Label (Image02)

This is a description of Mycophenolic Acid Delayed-Release Tablets, USP, containing 120 tablets each with mycophenolic acid 360 mg. Manufactured for Biocon Pharma Inc. They are intended for prescription use only and should be stored between 15°C and 30°C. The pharmacist is instructed to provide a Medication Guide to each patient, and the tablets should be dispensed in a tight container to protect from moisture and kept out of children's reach. The usual dosage information can be found in the package insert.*

FDA Label Image

Image Description (Structure0001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.